Home Stock

Stock Research: Virbac

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Virbac

PAR:VIRP FR0000031577
76
  • Value
    88
  • Growth
    26
  • Safety
    Safety
    77
  • Combined
    73
  • Sentiment
    82
  • 360° View
    360° View
    76
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Virbac SA is a veterinarian pharmaceutical company specializing in developing and producing vaccines and medicines. It operates in the pharmaceutical industry, offering pet and livestock medications, as well as food and identification chips for pets. Production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. In the last fiscal year, the company had a market cap of $3,328 million, profits of $971 million, and revenue of $1,447 million, with 5620 employees.

more
Strongest Rank Growth
Weakest Rank Value
Country France
Industry Pharmaceuticals
Size Small
Website corporate.virbac.com
Index
CAC All
SBF 120
Sound Pay Europe
Virbac stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 19-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 60 47 52
Growth
26 79 59 97
Safety
Safety
77 85 84 62
Sentiment
82 79 78 50
360° View
360° View
76 92 94 84
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
69 38 41 1
Opinions Change
41 62 94 50
Pro Holdings
n/a 80 61 100
Market Pulse
54 65 53 49
Sentiment
82 79 78 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
88 60 47 52
Growth
26 79 59 97
Safety Safety
77 85 84 62
Combined
73 81 80 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
88 59 63 69
Price vs. Earnings (P/E)
70 54 33 32
Price vs. Book (P/B)
69 45 43 43
Dividend Yield
51 41 43 49
Value
88 60 47 52
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
34 62 42 45
Profit Growth
56 67 37 83
Capital Growth
45 95 40 98
Stock Returns
38 35 96 100
Growth
26 79 59 97
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
60 78 76 63
Refinancing
61 50 61 44
Liquidity
61 68 79 48
Safety Safety
77 85 84 62

Similar Stocks

Discover high‑ranked alternatives to Virbac and broaden your portfolio horizons.

Grifols

MCE:GRF
Country: Spain
Industry: Biotechnology
Size: X-Large
Full Stock Analysis

L.D.C.

PAR:LOUP
Country: France
Industry: Packaged Foods & Meats
Size: Large
Full Stock Analysis

Rubis

PAR:RUI
Country: France
Industry: Gas Utilities
Size: Large
Full Stock Analysis

Krka

LJU:KRKG
Country: Slovenia
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

The stock offers good value, safe financing, and positive sentiment. However, it has below-average growth expectations. It is well-suited for conservative buy-and-hold investors who prioritize stability and low valuation over growth.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews